Work

PLX3397 Is An Investigational Selective FLT3 Inhibitor That Retains Activity Against the Clinically-Relevant FLT3-ITD/F691L “Gatekeeper” Mutation in Vitro

Year: 2011

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v118.21.764.764

Authors: Catherine C. Smith, Alexander E Perl, Elisabeth Lasater, Chao Zhang, Grace R Jeschke, Lauren E. Damon, Martin Carroll, Neil P. Shah

Institutions: University of California, San Francisco, Abramson Cancer Center, University of Pennsylvania, Plexxikon (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551150153

Cites:

Cited by: 10

Related to: 10